Conference Schedule

November 2024 conference schedule:

Recent Visiting Speakers:

2024-2025

• Dr. Samir M. Parikh, Chief, Division of Nephrology, Professor of Internal Medicine, Professor of Pharmacology, Robert Tucker Hayes Distinguished Chair in Nephrology in honor of Dr. Floyd C. Rector Jr. Ruth W. and Milton P. Levy, Sr. Chair in Molecular Nephrology, “Turning Back Kidney Frailty by Targeting Metabolism” 
• Dr. Ryan Williams, Assistant Professor of Medicine, Biomedical Engineering, City College of New York, “Renal-Targeted Nanomedicine to treat acute and chronic kidney diseases" 
• Dr. Mira Krendel Professor and Interim Chair, SUNY Upstate Medical University, Department of Cell and Developmental Biology, “Cell biology of steroid-resistant nephrotic syndrome: focus on the podocyte cytoskeleton” 
• Dr. Opeyemi Olabisi, MD, PhD Associate Professor of Medicine, Duke University, “Deciphering the pathomehanisms and therapeutic targets of APOL1 Kidney Disease”
• Dr. Laura Perin, Vice Chair of Research Surgery, Associate Professor, GOFARR Lab, USC Keck School of Medicine, "New Approaches to Glomerular Regeneration" 

2023-2024

• Dr. Benjamin D. Humphreys, MD, PhD Professor of Medicine Washington University School of Medicine St. Louis Missouri, Division of Nephrology, “Identifying AKI and CKD Mechanisms Using Single Cell Multiomics and Spatial Transcriptomics” 
• Dr. Karl Nath, MB, ChB Professor of Medicine, Mayo Clinic College of Medicine Department of Internal Medicine, Division of Nephrology & Hypertension, “Rhabdomyolysis and beyond” 
• Dr. Heddwen Brooks Professor and Chair Department of Physiology, Tulane University School of Medicine, “Sex differences in hypertension, inflammation and diabetic kidney disease” 
• Dr. Kamalika Mukherjee, Faculty of Medicine of Harvard University, "A single therapeutic target for diverse kidney diseases” 
• Dr. Matthew K. Abramowitz, MD, MS Montefiore Medical Center Attending Physician, Division of Nephrology, Department of Medicine “Functional Decline and Premature Aging in CKD” 
• Dr. Sharon Moe, MD, FACP, FAHA, FASN, FASBMR, Indiana University School of Medicine, Stuart A. Kleit Professor of Medicine and Professor of Anatomy & Cell Biology, Director, Division of Nephrology Associate Dean for Clinical and Translational Science, Distinguished Professor, “Uremic toxins and cardiovascular risk and fracture:  Is the intestine a surrogate nephron?”
• Dr. Tara I. Chang, MD, MS, FASN Division Chief, Professor Medicine, The Stanford University, Professor of Nephrology, Endowed Chair Stanford University, Division of Nephrology “How Low can You Go? Blood Pressure Management in CKD” 
• Dr. Katalin Susztak, MD, PhD Professor Medicine (Nephrology), Perelman School of Medicine, University of Pennsylvania, “The Multi-omics playbook to understand the mechanism of chronic Kidney disease” 
• Dr. Simone Sanna-Cherchi, MD Associate Professor of Medicine, Division of Nephrology, Columbia University, “Human genetic studies to solve mechanisms and facilitate novel therapies development for idiopathic nephrotic syndrome”
• Dr. Benjamin Freedman, Ph.D. University of Washington School of Medicine, “Modeling Kidney Disease and Regeneration with Human Pluripotent Stem Cells”
• Dr. Rajgopal Govindarajan  Professor and Chair  Division of Pharmaceutics & Pharmacology, College of Pharmacy The Ohio State University, “Nucleoside drug transporters: Role in disease and drug development” 
• Dr. Jai Radhakrishnan, MD, MS Professor of Medicine at Columbia University Medical Center Clinical Director, Division of Nephrology, New York Presbyterian Hospital “Dysproteinemia and Kidney Disease” 

2022-2023

• Amandeep Bajwa. PhD  Associate Professor Department of Surgery Division of Transplant Surgery University of Tennessee Health Science Center “ Interplay of Mitochondria and Metabolism in Obesity Related to Kidney Injury” 
• Vesh Srivatana, MD Director of Peritoneal Dialsys, The Rogosin Institute, NY “Preitoneal Dialsyis in the time of COVID"
• Lloyd Cantley, MD C.N. H. Long Professor of Medicine Vice Chair for Research, Department of Medicine Co-Director of Education, Yale Center for Clinical Investigation “The Complex Interplay between Acute Kidney Injury and Innate Immunity” 
• Karen Warburton, MD University of Virginia Health System Division of Nephrology “The Evolving Paradigm of Live Kidney Donor Risk Assessment” 
• Johanthan M. Barasch, MD, PhD. Lambert Professor of Medicine & Cell Biology Columbia University “Capture of Iron:  AKI, UTI and Identity Crises” 
• Dr. David Ellison, MD Professor of Medicine, Division of Nephrology and Hypertension, School of Medicine Professor of Physiology and Pharmacology, School of Medicine OHSU Nephrology and Hypertension Clinic, Marquam Hill Oregon Health & Science University, "New Insights into Salt Balance and Hypertension” 
• Amir Kazory, MD, FASN, FACC Professor and Chief J. Robert Cade Chair in Nephrology Division of Nephrology, Hypertension, and Renal Transplantation University of Florida “The Kidney-Heart Connection Drama; a Play in 3 Acts”
• Dean Sheppard, MD Professor, Department of Medicine University of California San Francisco “Cellular Cross-Talk Driving Tissue Fibrosis”
• Steven Fishbane, MD Chief, Division of Nephrology for Northwell Health Vice President and managing Director for Kidney Service, Northwell Health Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell “Background for the Dialize/Outcomes Study – Hyperkalemia and outcomes in Hemodialysis"
• Jeffrey H. Miner, MD Washington University School of Medicine Division of Nephrology, Eduardo and Judith Slatopolsky, Professor of Medicine in Nephrology Professor of Cell Biology and Physiology “Manipulating Glomerular Basement Membrane Composition in Alport Syndrome” 
• Tarek M. Ashkar, MD Indiana University School of Medicine Professor of Medicine Adjunct Professor of Anatomy, Cell Biology and Physiology, “Uromodulin: a key regulator of renal homeostasis and adaptation to kidney injury”  
• Alessia Fornoni, MD PhD FASN University of Miami, Miller School of Medicine Professor of Medicine and Molecular and Cellular Pharmacology Chief of the Katz Family Division of Nephrology and Hypertension, “Glomerular Lipids and Fatty Kidney Disease” 
• Dr. Roderick Tan, MD Assistant Professor of Medicine Department of Medicine, University of Pittsburgh School of Medicine “The Current View on NRF2 in Kidney Disease” 
• Janos Peti-Peterdi, MD, PhD.  University of Southern California, “Regenerative and neuron-like functions of the nephron central command”
• Alexander Staruschenko, PhD. University of South Florida Department of Molecular Pharmacology and Physiology, “Renal Potassium Channels in Salt Handling and Blood Pressure Control” 
• Dr. Markus Rinschen, MD Associate Professor, Department of Biomedicine Aarhus University University Hospital Hamburg Eppendorf, Germany, “Metabolic Communication in SGLT2 Inhibition”    

2020-2021

• Jordan Nestor, MD, Columbia University, “Operationalizing the return of genomic results”
• Vipul Chitalia, MD, Boston University School of Medicine,, “Universe of Uremic Toxicity”
• Sarah Huen, MD, UT Southwestern Medical Center, “Metabolism as Disease Tolerance:  Implications for Sepsis-associated AKI”
• Michal Melamed, MD, Albert Einstein College of Medicine, “Metabolic Acidosis in Kidney Diseases:  When to Treat?
• Krisztian Stadler, Ph.D, “Mitochondrial substrate balance, nutrient overload and chronic kidney disease”
• Fangming Lin, MD, Columbia University Irving Medical Center, “Renal stress response: a counteracting mechanism in the development of chronic kidney disease”
• Daria Ilatovskaya, MS, PhD, FAHA, Medical University of South Carolina, “The effects of ANP on mitochondrial bioenergetics in salt-sensitive hypertension” (DOM Research Seminar)
• Katherine Kelly, MD, MSc, Indiana University, “COVID19 & The Kidney”
• Eric Cohen, MD, University of Maryland School of Medicine, “Measurement of renal cortical fibrosis by CT scan”
• Rasha El-Rifai, MD, Assistant Professor, University of Minnesota, Department of Medicine, Division of Nephrology and Hypertension, “APO-L1 in Kidney Transplantation”
• Samira Farouk, MD, MSCR, FASN Assistant Professor, Division of Nephrology Icahn School of Medicine at Mount Sinai, “Innovations in Medical Education (Before) and During COVID-19: Beyond Zoom”
• David Goldfarb, MD, FACP, FASN, FNKF – Professor of Medicine and Physiology – NYU Grossman School of Medicine, “Update on Nephrolithiasis”
• Moshe Levi, M.D., Dean for Research, Professor of Biochemistry and Molecular & Cellular Biology, Georgetown University, "Effects of restoring NAD metabolism with Nicotinamide Riboside on mitochondrial function, inflammation, and kidney disease" 
• Lewis Kaufman, MD, Associate Professor of Medicine, Icahn School of Medicine at Mount Sinai, “Daschund-1 (DACH1) epigenomic regulation of glomerular disease susceptibility” 
• Mary E. Choi, M.D., Professor of Medicine at Weill Cornell Medical College (WCMC), “Mitochondria and Necroptosis – New Insights into Human and Experimental Kidney Disease”
• Christian, Faul, PhD, Associate Professor of Medicine, The University of Alabama at Birmingham, “The Pathologic Actions of FGF23 in Chronic Kidney Disease"
• Neil Hukriede, PhD, Professor and Vice-Chair Department of Developmental Biology Director, Integrative Systems Biology University of Pittsburgh, “Hdac8 – Therapeutic Target for Acute Kidney Injury”
• Dr. Chirag Parikh, Director of Nephrology, John Hopkins University, Baltimore “Novel Biomarkers for Phenotyping Clinical Acute Kidney Injury"
• Moshe, Levi MD, Dean for Research, Professor of Biochemistry and Molecular and Cellular Biology, Georgetown University, "Effects of restoring NAD metabolism with Nicotinamide Riboside on mitochondrial function, inflammation, and kidney disease"

2019-2020

• Matthew Wilson, MD, PhD, Vanderbilt University, “Engineering a novel cell therapy for sustained therapeutic protein delivery in vivo” (DOM Research Seminar)

• Youhua Liu, PhD, University of Pittsburgh, “Interstitial fibroblasts after kidney injury: Friends or foes?” (DOM Research Seminar)

• Marcus Bitzer, MD, University of Michigan, "The Increasing Complexity of MicroRNA Functions in the Kidney" (DOM Research Seminar)

• Rebecca J. Schmidt, DO, FACP, FASN, West Virginia University School of Medicine, "Billing and Payment for Kidney Health Care: Past, Present and Future Influences"
• Jonathan Winston, MD, Mount Sinai School of Medicine, "Overview and Management of Hyperkalemia"
• Jochen Reiser, MD, PhD, Rush University Medical Center, "Soluble urokinase receptor: risk factor and therapeutic target in kidney diseases"
• Alaa S. Awad, MD, PhD, University of Texas - San Antonio, "Arginase/Nitric Oxide Interaction in Diabetic Nephropathy"

2018-2019

• Alp Ikizler, MD, Vanderbilt University School of Medicine, "Management of Patients with Advanced Kidney Disease: Successes, Failures and Future Targets"
• Ryuji Morizane, MD, PhD, Harvard Medicial School, "Kidney organoids for disease modeling and regenerative medicine" 
• Anjay Rastogi, MD, University of California - Los Angeles, "Advancing the management of ADPKD"
• Vivek Bhalla, MD, Stanford University Medical Center, "Diverse nephron cell type-specific adaptation to furosemide revealed by single cell analysis"
• Belinda Jim, MD, FACP, Albert Einstein College of Medicine, "Hypertension in pregnancy" 
• Bhasker Chandra Das, PhD, Weill Cornell Medical College, Research seminar guest speaker
• Takashi Hato, MD, Indiana University School of Medicine, "Sepsis and Acute kidney injury"
• Madhav Menon, MD, Icahn School of Medicine at Mt. Sinai, Renal Ground Rounds Guest Speaker, "Dichotomous roles of Shroom3 in Tubular cells and Podocytes are motif dependent"
• Rujun Gong, MD, PhD, Brown University School of Medicine, "Therapeutic targeting of glycogen synthase kinase 3 beta in kidney disease" 
• Sumit Mohan, MD, MPH, Columbia University, "Kidney Transplantation, Discards and the Challenges of Precision Medicine" 
• Leah J. Siskind, PhD, University of Louisville, "Understanding Mechanisms of Cisplatin-Induced Nephrotoxicity" (DOM Research Conference)
• Joseph Vassalotti, MD, Mount Sinai School of Medicine, "Blood pressure control in CKD: Adapting guidelines to individualized care"
• Robert Bacallao, MD, Indiana University School of Medicine, "Mathematical models of cyst formation in ADPKD insights from computer based modeling" (DOM Research Seminar)
• Rajnish Mehrotra, MD, University of Washington, "Current State of Dialysis Therapies" (DOM Grand Rounds)
• George N. Coritsidis, MD, Mount Sinai School of Medicine, "Renal Function in the Critically Ill" and "The Undocumented Immigrant and ESRD"

2017-2018

• Leslie Gewin, MD, Vanderbilt University School of Medicine (DOM Research Conference)
• Eliyahu Khankin, MD, Beth Israel Deaconess Medical Center (Renal Grand Rounds)
• John Richard Lee, MD, Weill Cornell Medicine (DOM Research Conference)
• Anupam Agarwal, MD, The University of Alabama at Birmingham School of Medicine (DOM grand rounds) 
• David Basile, PhD, Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine (DOM Research Conference) 
• Julie Paik, MD, MPH, Brigham and Women's Hospital (DOM Research Conference) 
• Jeffrey Kopp, MD, Chief, Kidney Diseases Branch, NIDDK/NIH, “Focal Segmental Glomerulosclerosis and the African American predilection for kidney disease” 
• Sanja Sever, PhD, Massachusetts General Hospital, "Multiple roles of dynamin-actin interactions in kidney"
• Jaime Uribarri, MD, Director of Peritoneal Dialysis Mount Sinai School of Medicine, "Advances in Peritoneal Dialysis"

2016-2017:

• Kumar Sharma, MD, University of California, San Diego, “Novel role of mitochondria in diabetic complications”
• Sumant Chugh, MD, Rush Medical College, “Transcriptional regulation in podocyte disease”
• Michael Ross, MD, Icahn School of Medicine at Mt. Sinai, “Kidney Injury in HIV positive patients”
• Peter Heeger, MD, Icahn School of Medicine at Mt. Sinai, "An expanded role for complement in transplant rejection"
• Kirk Campbell, MD, Icahn School of Medicine at Mt. Sinai, “Novel mediators of pedocyte survival in glomerular disease progression”
• Ramon Bonegio, MD, Boston University, "Toll-like receptor pathways promote sterile inflammation in immune complex glomerulonephritis"

2015-2016:

• Ali Gharavi, MD, Columbia University, “Genetics of IgA Nephropathy”
• Raymond Townsend, MD, University of Pennsylvania, “HTN in the post-SPRINT Era”
• Stuart Shankland, MD, University of Washington, “Making Sense of Glomerular Diseases”
• David Goldfarb, MD, NYU, “Update on Nephrolithiasis”
• Vishal S. Vaidya, Ph.D. Brigham & Women’s Hospital, "Translational and Mechanistic Biomarkers of Kidney Disease"
• Roy Zent, MD, PhD, Vanderbilt University, "The Glomerular Filtration Barrier"

2014-2015:

• Charles Jennette, MD, North Carolina @ Chapel Hill “Overview of Vasculitis: Historical Perspective, Clinical and Pathologic and Pathogenic concepts”
• Ananth Karumanchi, MD, Harvard Medical School, “Pathogenesis of Pre-eclampsia”
• John C. He, MD, Icahn School of Medicine at Mt. Sinai 
• Avi Ma’ayan PhD, Icahn School of Medicine at Mt. Sinai